SAREPTA THERAPEUTICS INC's ticker is SRPT and the CUSIP is 803607100. A total of 409 filers reported holding SAREPTA THERAPEUTICS INC in Q3 2020. The put-call ratio across all filers is 1.18 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2021 | $52,000 | -56.3% | 700 | 0.0% | 0.00% | -60.0% |
| Q4 2020 | $119,000 | +21.4% | 700 | 0.0% | 0.01% | 0.0% |
| Q3 2020 | $98,000 | -12.5% | 700 | 0.0% | 0.01% | -23.1% |
| Q2 2020 | $112,000 | +64.7% | 700 | 0.0% | 0.01% | +30.0% |
| Q1 2020 | $68,000 | -24.4% | 700 | 0.0% | 0.01% | -9.1% |
| Q4 2019 | $90,000 | 0.0% | 700 | -41.7% | 0.01% | 0.0% |
| Q3 2019 | $90,000 | – | 1,200 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Perceptive Advisors | 2,878,979 | $69,182,000 | 7.27% |
| Eventide Asset Management | 259,100 | $6,226,000 | 0.97% |
| GLADE BROOK CAPITAL PARTNERS LLC | 251,000 | $6,032,000 | 0.93% |
| IMS Capital Management | 32,215 | $774,000 | 0.91% |
| Perceptive Advisors | 350,000 | $8,413,000 | 0.88% |
| Benchmark Capital Advisors | 34,900 | $839,000 | 0.58% |
| BECK CAPITAL MANAGEMENT, LLC | 24,744 | $636,000 | 0.49% |
| SABBY MANAGEMENT, LLC | 352,100 | $8,461,000 | 0.47% |
| Hatteras Alternative Mutual Funds, LLC | 39,404 | $947,000 | 0.46% |
| Potomac Capital Management, Inc. | 22,100 | $531,000 | 0.45% |